Key Role of STAT3 in Osteoarthritis: From Pathogenic Mechanisms to Targeted Therapy

Area of Science:

• Biomedical Science
• Molecular Biology
• Rheumatology

Background:

• Osteoarthritis (OA) is a degenerative joint disease with unclear pathogenesis and limited treatments.
• Signal transducer and activator of transcription 3 (STAT3) is implicated in OA pathogenesis.
• The Janus kinase (JAK)/interleukin-6/STAT3 pathway is vital in OA development.

Purpose of the Study:

• To review STAT3 signaling pathways in OA.
• To explore STAT3's roles in various cell types within OA.
• To discuss novel STAT3-targeting therapies for OA.

Main Methods:

• Literature review of signaling pathways involving STAT3 in OA.
• Analysis of STAT3's function in different cell types.
• Systematic discussion of therapeutic strategies targeting STAT3.

Main Results:

• STAT3 is involved in multiple signaling pathways critical to OA.
• STAT3 plays diverse roles in OA pathogenesis across different cell types.
• Emerging therapies focus on STAT3 for enhanced OA treatment.

Conclusions:

• Understanding STAT3 mechanisms in OA is key for developing effective treatments.
• Targeting the STAT3 pathway holds promise for future OA therapeutics.
• Further research on STAT3 is essential for advancing OA management.